Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02461095 · ClinicalTrials.gov registry record · NA
Evaluation of a Treatment Algorithm for Patients With Patellofemoral Pain Syndrome
A NA study of Patellofemoral Pain Syndrome, sponsored by Nationwide Children's Hospital.
- Completed
- Registry status
- NA
- Development phase
- 55
- Enrollment target
- 4
- Study locations
NCT02461095 is a NA study of Patellofemoral Pain Syndrome that has completed, run by Nationwide Children's Hospital. The registered enrollment target is 55 participants, below the 141-participant average among 10 other Patellofemoral Pain Syndrome trials with a reported enrollment target (61% lower). The trial reports 4 study locations across 1 state.
The verdict
NCT02461095, a NA study of Patellofemoral Pain Syndrome, has completed, sponsored by Nationwide Children's Hospital.
- COMPLETED
- Registry status
- NA
- Development phase
- 55 participants
- Enrollment target
- 4
- Study locations
Study Summary
Patients with PFPS demonstrate quadriceps and hip musculature weakness, altered lower extremity (LE) kinematics, and decreased LE flexibility. Psychosocial factors have also been identified as an important factor in patients with PFPS. The authors hypothesize that an ordered approach addressing each of these impairments sequentially will result in greater improvement in PFPS symptoms. The results of the investigators pilot study assessing the feasibility of using a sequential approach showed a full randomized controlled trial is warranted, the authors now plan to proceed with a full trial. The objective of this study is to assess the efficacy of a sequential approach in the treatment of Patellofemoral Pain Syndrome. Methods: Patients will be randomized to a sequential treatment approach using a PFPS treatment algorithm (PFPS Algorithm) designed by the authors or typical physical therapy care. Due to the constant evaluation necessary no blinding will be performed. Patients will attend therapy two times per week for six weeks. Pain, Anterior Knee Pain Scale (AKPS), and Global Rating of Change (GROC) will be measured at evaluation and discharge, 3 month follow-up and 6 month follow-up.
Conditions Studied
Interventions
- OTHER Impairment based approach
- OTHER PFPS Algorithm approach
Study Locations (4)
Ohio
- Nationwide Children's Hospital Sports and Ortho PT East Broad - Columbus
- Nationwide Children's Hospital Sports and Ortho PT Dublin - Dublin
- Nationwide Children's Hospital Sports and Ortho PT New Albany - New Albany
- Nationwide Children's Hospital Sports and Orthopedic PT Westerville location - Westerville
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 55 participants |
| Start Date | 2015-06 |
| Est. Completion | 2017-10 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02461095
The ClinicalTrials.gov registry entry for NCT02461095 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 55 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 141-participant average among 10 other Patellofemoral Pain Syndrome trials with a reported enrollment target (61% lower). The listed sponsor is Nationwide Children's Hospital, which has 188 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Patellofemoral Pain Syndrome appearing as the primary indexed condition, and to 2 interventions - of which Impairment based approach is the first listed.
NCT02461095 reports 4 study locations spanning 1 distinct geographic area - top geographies include Ohio.
Frequently Asked Questions
What is clinical trial NCT02461095 about?
NCT02461095 is a clinical study titled "Evaluation of a Treatment Algorithm for Patients With Patellofemoral Pain Syndrome". Patients with PFPS demonstrate quadriceps and hip musculature weakness, altered lower extremity (LE) kinematics, and decreased LE flexibility. Psychosocial factors have also been identified as an important factor in patients with PFPS. The authors hypothesize that an ordered approach addressing each...
What is the current status of trial NCT02461095?
This trial is currently completed. It is a NA study. The enrollment target is 55 participants. The study started on 2015-06. Estimated completion is 2017-10.
What conditions does trial NCT02461095 study?
This clinical trial studies the following conditions: Patellofemoral Pain Syndrome.
What interventions are being tested in trial NCT02461095?
The interventions under investigation include: Impairment based approach (OTHER), PFPS Algorithm approach (OTHER).
Who is sponsoring clinical trial NCT02461095?
This trial is sponsored by Nationwide Children's Hospital, which has 188 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT02461095 being conducted?
This trial has 4 study locations across Ohio. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Patellofemoral Pain Syndrome
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Mindful Miles Pilot Feasibility Study
RECRUITING · NA
-
The Effects of Dry Needling on Patients With Knee Pain
RECRUITING · NA
-
Emovi 3D Knee Assessment Device Intervention for Operational Readiness
RECRUITING · NA
-
Modulating Cortical Excitability to Improve Functional Movements in Individuals With Patellofemoral Pain
RECRUITING · NA
-
Trial of Neurostimulation and Blood Flow Restriction for PFPS in Active Duty
COMPLETED · NA
-
Utilizing the Trunk as a Proximal Lever to Strengthen the Hip Musculature and Alter Lower Extremity Function
COMPLETED · NA
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.